Catabasis Pharma (CATB) Tops Q4 EPS by 5c

Catabasis Pharma (NASDAQ: CATB) reported Q4 EPS of ($0.85), $0.05 better than the analyst estimate of ($0.90).

For earnings history and earnings-related data on Catabasis Pharma (CATB) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49